The store will not work correctly when cookies are disabled.
2-isobutyl-3-(4-methoxyphenyl)-10-methylpyrimido[4,5-b]quinoline-4,5(3H,10H)-dione
ID: ALA4756163
PubChem CID: 85090338
Max Phase: Preclinical
Molecular Formula: C23H23N3O3
Molecular Weight: 389.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-n2c(CC(C)C)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1
Standard InChI: InChI=1S/C23H23N3O3/c1-14(2)13-19-24-22-20(21(27)17-7-5-6-8-18(17)25(22)3)23(28)26(19)15-9-11-16(29-4)12-10-15/h5-12,14H,13H2,1-4H3
Standard InChI Key: KBAXOGFMEONMFW-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
19.3938 -15.9703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3927 -16.7977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1074 -17.2105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1056 -15.5576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8211 -15.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8218 -16.7935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5371 -17.2044 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5315 -15.5525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2473 -15.9598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2509 -16.7893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9700 -17.1992 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6860 -16.7806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6783 -15.9479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9586 -15.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5270 -14.7276 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9515 -14.7169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.3836 -15.5296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1021 -15.9370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8121 -15.5184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8048 -14.6926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0815 -14.2872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3744 -14.7081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3989 -17.1870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4030 -18.0129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1163 -18.4200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6905 -18.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5147 -14.2724 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.2336 -14.6771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5392 -18.0294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
8 5 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 9 1 0
8 15 2 0
14 16 2 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
23 24 1 0
24 25 1 0
12 23 1 0
24 26 1 0
20 27 1 0
27 28 1 0
7 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 389.46 | Molecular Weight (Monoisotopic): 389.1739 | AlogP: 3.44 | #Rotatable Bonds: 4 |
Polar Surface Area: 66.12 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.07 | CX LogD: 4.07 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.50 | Np Likeness Score: -0.81 |
References
1. Luderman KD,Jain P,Benjamin Free R,Conroy JL,Aubé J,Sibley DR,Frankowski KJ. (2021) Development of pyrimidone D1 dopamine receptor positive allosteric modulators., 31 [PMID:33221389] [10.1016/j.bmcl.2020.127696] |